BRAIN Biotech AG Cash Flow Conversion Efficiency

Latest as of September 2025: -2.326x

BRAIN Biotech AG cash flow conversion efficiency. Based on the latest financial reports, BRAIN Biotech AG (BNN) has a cash flow conversion efficiency ratio of -2.326x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-4.28 Million ≈ $-5.01 Million USD) by net assets (€1.84 Million ≈ $2.15 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of BRAIN Biotech AG (2012–2025)

Cash flow conversion efficiency of BRAIN Biotech AG from 2012 to 2025. This chart illustrates how BRAIN Biotech AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. View BNN live share price for real-time trading data and today's change.

BRAIN Biotech AG Cash Flow Conversion Ratio Explained

BRAIN Biotech AG cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

BRAIN Biotech AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BRAIN Biotech AG ranked by their cash flow conversion efficiency. Also see BRAIN Biotech AG stock valuation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
JR Invest SA WAR:JRH	-0.014x
Futuretech II Acquisition Corp NASDAQ:FTII	-3.681x
Gogoro Inc NASDAQ:GGR	0.204x
Vbt Yazilim AS IS:VBTYZ	-0.057x
Stefstock JSE:SSK	-2.100x
Lida Holdings Ltd TW:4552	0.005x
Dsr Wire KO:069730	0.007x
iBio, Inc. Common Stock NASDAQ:IBIO	-0.073x

Annual Cash Flow Conversion Efficiency for BRAIN Biotech AG (2012–2025)

The table below shows the annual cash flow conversion efficiency of BRAIN Biotech AG from 2012 to 2025. Review BNN free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-09-30	€1.84 Million ≈ $2.15 Million	€-9.23 Million ≈ $-10.79 Million	-5.015x	-1843.65%
2024-09-30	€13.89 Million ≈ $16.23 Million	€-3.58 Million ≈ $-4.19 Million	-0.258x	-40.78%
2023-09-30	€23.01 Million ≈ $26.91 Million	€-4.22 Million ≈ $-4.93 Million	-0.183x	-322.69%
2022-09-30	€34.25 Million ≈ $40.04 Million	€-1.49 Million ≈ $-1.74 Million	-0.043x	+53.57%
2021-09-30	€41.83 Million ≈ $48.90 Million	€-3.91 Million ≈ $-4.57 Million	-0.093x	+48.79%
2020-09-30	€26.14 Million ≈ $30.56 Million	€-4.77 Million ≈ $-5.57 Million	-0.182x	+7.80%
2019-09-30	€17.09 Million ≈ $19.98 Million	€-3.38 Million ≈ $-3.95 Million	-0.198x	-11.84%
2018-09-30	€30.64 Million ≈ $35.82 Million	€-5.42 Million ≈ $-6.33 Million	-0.177x	-45.48%
2017-09-30	€47.36 Million ≈ $55.37 Million	€-5.76 Million ≈ $-6.73 Million	-0.122x	+62.31%
2016-09-30	€26.93 Million ≈ $31.48 Million	€-8.68 Million ≈ $-10.15 Million	-0.322x	+54.88%
2015-09-30	€5.76 Million ≈ $6.73 Million	€-4.11 Million ≈ $-4.81 Million	-0.715x	-153.56%
2014-09-30	€13.85 Million ≈ $16.19 Million	€-3.90 Million ≈ $-4.56 Million	-0.282x	-2.26%
2013-09-30	€17.59 Million ≈ $20.57 Million	€-4.85 Million ≈ $-5.67 Million	-0.276x	+43.22%
2012-09-30	€12.12 Million ≈ $14.17 Million	€-5.89 Million ≈ $-6.88 Million	-0.485x	--

About BRAIN Biotech AG

XETRA:BNN Germany Specialty Chemicals

Market Cap

$67.69 Million

€57.90 Million EUR

Market Cap Rank

#21592 Global

#1924 in Germany

Share Price

€2.65

Change (1 day)

-6.03%

52-Week Range

€2.16 - €3.66

All Time High

€27.50